| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| 10-1055-s-0041-17353..> | 2022-05-23 12:01 | 64K | ||
| 2004/ | 2023-06-07 05:58 | - | ||
| 2005/ | 2023-06-05 05:30 | - | ||
| 2006/ | 2023-06-02 07:31 | - | ||
| 2007/ | 2023-05-30 09:53 | - | ||
| 2008/ | 2023-05-23 11:48 | - | ||
| 2009/ | 2022-09-21 09:05 | - | ||
| 2010/ | 2022-09-20 04:39 | - | ||
| 2011/ | 2022-09-20 06:30 | - | ||
| 2012/ | 2022-09-01 05:56 | - | ||
| 2013/ | 2022-09-01 05:23 | - | ||
| 2014/ | 2022-09-02 07:49 | - | ||
| 2015/ | 2022-08-26 04:25 | - | ||
| 2016/ | 2022-08-18 03:45 | - | ||
| 2017/ | 2022-06-24 06:17 | - | ||
| 2018/ | 2022-05-30 10:24 | - | ||
| 2019/ | 2022-05-30 10:19 | - | ||
| 2020/ | 2022-05-30 10:22 | - | ||
| 2022/ | 2022-06-20 05:51 | - | ||
| 2023/ | 2023-05-15 11:06 | - | ||
| 2024/ | 2024-03-20 03:53 | - | ||
| 2025/ | 2025-02-07 07:21 | - | ||
| Challenges in Care o..> | 2021-08-09 12:05 | 20M | ||
| a-case-report-of-pri..> | 2021-07-20 07:44 | 389K | ||
| a-case-report-of-pri..> | 2021-08-07 11:54 | 19M | ||
| a-descriptive-study-..> | 2021-08-13 12:01 | 107K | ||
| a-prospective-study-..> | 2022-03-14 05:15 | 555K | ||
| a-radiologists-persp..> | 2022-02-16 11:38 | 3.0M | ||
| a-rare-case-of-carci..> | 2021-06-15 13:36 | 739K | ||
| a-rare-occurrence-of..> | 2021-12-02 08:16 | 6.0M | ||
| a-rare-presentation-..> | 2021-06-15 13:36 | 190K | ||
| a-retrospective-obse..> | 2021-10-20 10:50 | 289K | ||
| a-retrospective-obse..> | 2022-01-06 10:47 | 216K | ||
| a-retrospective-stud..> | 2021-09-22 19:16 | 7.3M | ||
| adjuvant-trastuzumab..> | 2021-09-22 19:15 | 314K | ||
| administration-and-t..> | 2022-05-24 10:49 | 189K | ||
| administration-and-t..> | 2021-12-30 12:57 | 189K | ||
| administration-and-t..> | 2021-12-14 11:13 | 270K | ||
| adult-soft-tissue-sa..> | 2021-12-02 08:16 | 595K | ||
| alk-inhibitors-in-no..> | 2021-06-15 13:36 | 681K | ||
| an-analysis-of-acute..> | 2021-08-13 12:01 | 84K | ||
| angiogenesis-in-canc..> | 2021-08-07 11:53 | 2.1M | ||
| antiemetic-regimen-w..> | 2021-12-02 08:18 | 362K | ||
| application-of-healt..> | 2021-12-30 12:55 | 192K | ||
| artificial-intellige..> | 2022-01-06 10:48 | 245K | ||
| assessment-of-baseli..> | 2022-03-15 05:17 | 152K | ||
| ayurveda-maintenance..> | 2022-02-15 09:39 | 196K | ||
| barriers-and-support..> | 2021-08-07 11:37 | 544K | ||
| bilateral-cmv-retini..> | 2022-05-27 09:21 | 693K | ||
| blastic-plasmacytoid..> | 2021-12-30 12:57 | 476K | ||
| blastic-plasmacytoid..> | 2021-12-09 05:37 | 6.7M | ||
| breast-imaging-past-..> | 2022-02-16 11:38 | 834K | ||
| building-a-foundatio..> | 2022-02-16 11:38 | 164K | ||
| can-cancer-survivors..> | 2021-06-15 13:36 | 202K | ||
| cancer-treatment–i..> | 2021-09-22 19:16 | 5.7M | ||
| cancer-vaccine-in-so..> | 2021-12-02 08:17 | 400K | ||
| central-venous-cathe..> | 2021-09-22 19:15 | 286K | ||
| cervical-angiomyolip..> | 2021-09-22 19:16 | 8.6M | ||
| changing-pattern-of-..> | 2021-12-30 12:55 | 231K | ||
| chemotherapy-delays-..> | 2021-06-15 06:27 | 1.1M | ||
| chimeric-antigen-rec..> | 2021-06-15 13:36 | 1.0M | ||
| chondrosarcoma-of-th..> | 2021-12-30 12:55 | 221K | ||
| classical-hodgkin-ly..> | 2022-02-15 09:39 | 387K | ||
| clinical-and-postope..> | 2021-12-02 08:16 | 361K | ||
| clinical-morphologic..> | 2022-01-06 10:47 | 559K | ||
| clinical-trials-in-i..> | 2021-09-22 19:15 | 236K | ||
| clinically-undetecte..> | 2022-01-06 10:47 | 403K | ||
| comparison-of-variou..> | 2021-08-13 12:01 | 107K | ||
| compliance-of-radiot..> | 2022-03-04 15:14 | 238K | ||
| controversies-in-med..> | 2021-12-30 12:55 | 245K | ||
| coronavirus-disease-..> | 2021-06-15 06:27 | 222K | ||
| coronvirus-disease-2..> | 2021-06-14 17:25 | 379K | ||
| correlation-between-..> | 2021-06-15 06:27 | 2.2M | ||
| covid-19-cancer-and-..> | 2021-06-15 06:27 | 385K | ||
| cross-sectional-stud..> | 2022-02-18 07:16 | 2.1M | ||
| crying-with-a-smile-..> | 2021-06-15 13:36 | 123K | ||
| current-treatment-ap..> | 2021-06-15 13:36 | 882K | ||
| dasatinib—a-genera..> | 2021-08-09 12:04 | 396K | ||
| determinants-of-comp..> | 2022-02-25 11:13 | 364K | ||
| diet-and-cancer-prev..> | 2021-09-22 19:15 | 181K | ||
| discriminatory-impac..> | 2022-02-16 11:38 | 1.6M | ||
| distant-metastasis-i..> | 2021-06-15 06:27 | 224K | ||
| dr-gouri-shankar-bha..> | 2021-08-07 11:24 | 3.7M | ||
| drug-repurposing-in-..> | 2021-08-09 12:05 | 13M | ||
| effect-of-menopausal..> | 2022-02-18 07:16 | 159K | ||
| efficacy-of-mobile-p..> | 2022-01-06 10:48 | 370K | ||
| emerging-role-of-hyp..> | 2022-01-06 10:47 | 103K | ||
| epidemiology-of-adol..> | 2021-08-13 12:01 | 98K | ||
| epigenetic-modificat..> | 2021-12-30 12:55 | 361K | ||
| epigenetic-modificat..> | 2022-05-24 09:04 | 361K | ||
| epithelial-ovarian-c..> | 2021-08-13 12:01 | 120K | ||
| evaluation-of-telome..> | 2021-08-13 12:01 | 84K | ||
| ewing-sarcoma-of-pha..> | 2022-03-15 05:17 | 3.4M | ||
| excellent-radiologic..> | 2021-06-15 13:36 | 1.7M | ||
| extra-nodal-follicul..> | 2022-05-27 08:56 | 4.2M | ||
| factors-affecting-sh..> | 2021-12-02 08:16 | 742K | ||
| factors-associated-w..> | 2022-03-15 05:17 | 192K | ||
| from-claps-to-slapsâ..> | 2021-09-22 19:16 | 295K | ||
| gender-climate-in-in..> | 2022-02-18 07:16 | 110K | ||
| geriatric-assessment..> | 2021-12-30 12:57 | 135K | ||
| geriatric-assessment..> | 2021-12-14 11:13 | 124K | ||
| gynecologic-oncology..> | 2022-02-16 11:38 | 199K | ||
| hairy-cell-leukemia-..> | 2022-01-06 10:47 | 352K | ||
| hematolymphoid-neopl..> | 2021-11-26 06:09 | 465K | ||
| hematolymphoid-neopl..> | 2021-12-30 12:55 | 401K | ||
| highlighting-differe..> | 2021-12-02 08:16 | 739K | ||
| how-i-treat-acute-pr..> | 2021-09-22 19:16 | 9.5M | ||
| how-i-treat-adult-ac..> | 2022-01-06 10:48 | 313K | ||
| how-i-treat-adult-ac..> | 2021-08-07 11:53 | 543K | ||
| how-i-treat-advanced..> | 2022-02-16 11:38 | 951K | ||
| how-i-treat-metastat..> | 2021-06-15 13:36 | 1.2M | ||
| how-i-treat-neuroend..> | 2021-12-30 12:57 | 258K | ||
| how-i-treat-neuroend..> | 2021-10-01 16:01 | 335K | ||
| how-we-treat-her2-po..> | 2021-12-02 08:16 | 220K | ||
| how-we-use-immunohis..> | 2022-02-16 11:38 | 609K | ||
| identifying-myeloma-..> | 2021-08-07 11:53 | 289K | ||
| ijmpo-a-journey-of-a..> | 2021-06-14 17:25 | 178K | ||
| ijmpo.ijmpo_10_19.pdf | 2022-05-27 11:11 | 1.1M | ||
| ijmpo.ijmpo_12_17.pdf | 2022-05-30 09:07 | 429K | ||
| ijmpo.ijmpo_15_20.pdf | 2022-05-27 10:39 | 411K | ||
| ijmpo.ijmpo_16_20.pdf | 2022-05-27 10:50 | 513K | ||
| ijmpo.ijmpo_46_19.pdf | 2022-05-28 05:52 | 515K | ||
| ijmpo.ijmpo_49_20.pdf | 2022-05-30 06:49 | 411K | ||
| ijmpo.ijmpo_64_19.pdf | 2022-05-28 07:08 | 620K | ||
| ijmpo.ijmpo_93_20.pdf | 2022-05-27 09:57 | 1.1M | ||
| ijmpo.ijmpo_113_19.pdf | 2022-05-28 08:53 | 1.2M | ||
| ijmpo.ijmpo_115_19.pdf | 2022-05-28 09:20 | 1.1M | ||
| ijmpo.ijmpo_118_19.pdf | 2022-05-30 07:01 | 411K | ||
| ijmpo.ijmpo_129_19.pdf | 2022-05-28 09:32 | 1.9M | ||
| ijmpo.ijmpo_172_19.pdf | 2022-05-27 10:56 | 477K | ||
| ijmpo.ijmpo_201_19.pdf | 2022-05-30 07:11 | 445K | ||
| ijmpo.ijmpo_239_14.pdf | 2022-05-30 09:35 | 501K | ||
| ijmpo.ijmpo_252_19.pdf | 2022-05-30 07:16 | 450K | ||
| ijmpo.ijmpo_263_19.pdf | 2022-05-30 10:20 | 750K | ||
| img/ | 2022-05-30 10:28 | - | ||
| immunotherapy-in-pat..> | 2021-08-13 12:01 | 99K | ||
| implications-for-ayu..> | 2021-12-11 06:29 | 178K | ||
| inferior-vena-cava-r..> | 2021-12-02 08:16 | 2.7M | ||
| inotuzumab-ozogamici..> | 2021-08-09 12:05 | 5.4M | ||
| intention-to-quit-to..> | 2021-12-30 12:55 | 223K | ||
| is-low-dose-abirater..> | 2022-02-16 11:38 | 169K | ||
| larotrectinib-a-nove..> | 2021-08-21 09:53 | 183K | ||
| larotrectinib-a-nove..> | 2021-09-22 19:16 | 291K | ||
| let-your-faith-be-bi..> | 2021-12-30 12:55 | 106K | ||
| liquid-biopsy.pdf | 2021-06-15 13:36 | 514K | ||
| locally-advanced-bre..> | 2021-08-07 11:37 | 31M | ||
| management-of-metast..> | 2021-09-22 19:16 | 683K | ||
| managing-life-threat..> | 2021-08-07 11:37 | 5.6M | ||
| massive-enlargement-..> | 2021-08-07 11:53 | 8.1M | ||
| maternity-and-childc..> | 2022-02-16 11:38 | 140K | ||
| measuring-satisfacti..> | 2021-12-02 07:11 | 158K | ||
| meta-analysis-for-us..> | 2021-09-22 19:16 | 4.1M | ||
| metastatic-extra-adr..> | 2022-02-15 09:39 | 580K | ||
| metastatic-lobular-c..> | 2022-02-16 11:38 | 1.5M | ||
| microbiome.pdf | 2021-12-30 12:55 | 154K | ||
| minimal-residual-dis..> | 2021-06-15 13:36 | 1.1M | ||
| modern-radiation-onc..> | 2022-02-16 11:38 | 165K | ||
| molecular-classifica..> | 2021-12-02 08:16 | 435K | ||
| moving-next-generati..> | 2021-09-22 19:16 | 2.1M | ||
| multidrug-resistant-..> | 2021-08-07 11:37 | 256K | ||
| multiple-complicatio..> | 2022-05-27 10:10 | 1.5M | ||
| nanotechnology-in-on..> | 2021-06-15 13:36 | 182K | ||
| nanotechnology-in-or..> | 2021-08-07 11:37 | 487K | ||
| newer-trial-designs.pdf | 2021-06-15 13:36 | 2.1M | ||
| nivolumab-a-new-stan..> | 2021-12-30 12:55 | 114K | ||
| nurses-on-the-frontl..> | 2022-02-18 07:16 | 1.6M | ||
| occurrence-of-epider..> | 2021-09-22 19:16 | 2.2M | ||
| orbital-metastasis-a..> | 2021-12-11 16:45 | 5.3M | ||
| outbreak-of-ralstoni..> | 2022-03-14 05:15 | 166K | ||
| outcome-of-cbv-carmu..> | 2022-02-15 09:39 | 1.0M | ||
| outcome-of-treatment..> | 2021-08-13 12:01 | 120K | ||
| palatal-mucormycosis..> | 2021-12-30 12:57 | 227K | ||
| palatal-mucormycosis..> | 2021-12-14 11:13 | 797K | ||
| patellar-metastasis-..> | 2022-01-06 10:48 | 147K | ||
| pediatric-oncology-p..> | 2021-08-07 11:53 | 504K | ||
| pembrolizumab-weight..> | 2022-05-27 06:50 | 4.8M | ||
| pembrolizumab-weight..> | 2022-02-21 10:51 | 210K | ||
| perception-and-impro..> | 2022-02-18 07:16 | 167K | ||
| persistent-antibody-..> | 2021-08-07 11:53 | 3.2M | ||
| personal-protective-..> | 2021-06-15 13:36 | 150K | ||
| pharmacoeconomics.pdf | 2021-09-22 19:16 | 314K | ||
| pitfalls-in-prostate..> | 2021-06-15 13:36 | 751K | ||
| post-denosumab-treat..> | 2021-12-02 08:16 | 6.9M | ||
| posttraumatic-growth..> | 2022-03-14 05:15 | 725K | ||
| potential-prognostic..> | 2021-09-22 19:16 | 4.5M | ||
| prevalence-and-deter..> | 2022-02-18 07:16 | 186K | ||
| primary-renal-neurob..> | 2021-12-02 08:16 | 444K | ||
| prognostic-significa..> | 2022-01-06 10:48 | 381K | ||
| psychological-status..> | 2021-08-13 12:01 | 87K | ||
| pulmonary-oncologist..> | 2022-02-16 11:38 | 121K | ||
| pulmonary-oncologyâ€..> | 2022-02-21 11:02 | 562K | ||
| quality-of-life-of-p..> | 2021-09-22 19:16 | 1.9M | ||
| radiation-recall-phe..> | 2021-06-15 13:36 | 211K | ||
| real-world-experienc..> | 2022-01-06 10:47 | 250K | ||
| real-world-outcome-o..> | 2021-12-14 11:13 | 866K | ||
| recent-advances-in-f..> | 2022-02-15 09:39 | 253K | ||
| relapsed-plasmablast..> | 2022-05-27 10:56 | 3.4M | ||
| retrospective-analys..> | 2022-01-06 10:47 | 185K | ||
| retrospective-analys..> | 2021-12-14 11:13 | 167K | ||
| retrospective-analys..> | 2021-06-15 06:27 | 453K | ||
| retrospective-study-..> | 2022-05-27 07:48 | 3.3M | ||
| role-of-interim-pet-..> | 2021-12-30 12:55 | 360K | ||
| role-of-interim-pet-..> | 2021-07-12 05:57 | 681K | ||
| rosette-forming-glio..> | 2021-09-22 19:16 | 5.5M | ||
| ruxolitinib-in-gluco..> | 2022-01-06 10:47 | 128K | ||
| s-0041-1729342.pdf | 2022-05-24 11:50 | 1.7M | ||
| s-0041-1729434.pdf | 2022-05-24 09:08 | 514K | ||
| s-0041-1729435.pdf | 2022-05-24 09:12 | 2.1M | ||
| s-0041-1729436.pdf | 2022-05-24 09:12 | 123K | ||
| s-0041-1729437.pdf | 2022-05-24 09:11 | 1.0M | ||
| s-0041-1729438.pdf | 2022-05-24 11:50 | 190K | ||
| s-0041-1729725.pdf | 2022-05-24 11:50 | 1.2M | ||
| s-0041-1729726.pdf | 2022-05-24 07:10 | 882K | ||
| s-0041-1729727.pdf | 2022-05-24 09:11 | 182K | ||
| s-0041-1729728.pdf | 2022-05-24 07:11 | 680K | ||
| s-0041-1729730.pdf | 2022-05-24 07:12 | 1.1M | ||
| s-0041-1729731.pdf | 2022-05-24 11:50 | 150K | ||
| s-0041-1729733.pdf | 2022-05-24 11:50 | 739K | ||
| s-0041-1730091.pdf | 2022-05-24 11:50 | 542K | ||
| s-0041-1730757.pdf | 2022-05-24 09:10 | 751K | ||
| s-0041-1731844.pdf | 2022-05-25 10:48 | 401K | ||
| s-0041-1731972.pdf | 2022-05-24 11:50 | 20M | ||
| s-0041-1731979.pdf | 2022-05-30 05:49 | 313K | ||
| s-0041-1732814.pdf | 2022-05-24 11:50 | 502K | ||
| s-0041-1732816.pdf | 2022-05-24 11:50 | 3.7M | ||
| s-0041-1732824.pdf | 2022-05-30 07:01 | 126K | ||
| s-0041-1732833.pdf | 2022-05-26 07:26 | 258K | ||
| s-0041-1733823.pdf | 2022-05-24 11:50 | 3.2M | ||
| s-0041-1735516.pdf | 2022-05-28 07:01 | 161K | ||
| s-0041-1735518.pdf | 2022-05-30 08:43 | 361K | ||
| s-0041-1735577.pdf | 2022-05-24 10:28 | 245K | ||
| s-0041-1735596.pdf | 2022-05-25 12:27 | 135K | ||
| s-0041-1735598.pdf | 2022-05-30 07:10 | 228K | ||
| s-0041-1735599.pdf | 2022-05-26 06:59 | 154K | ||
| s-0041-1736210.pdf | 2022-05-30 09:00 | 221K | ||
| s-0041-1736431.pdf | 2022-05-30 06:52 | 352K | ||
| s-0041-1736432.pdf | 2022-05-30 07:39 | 476K | ||
| s-0041-1736679.pdf | 2022-05-24 09:41 | 6.0M | ||
| s-0041-1736682.pdf | 2022-05-24 09:09 | 3.5M | ||
| s-0041-1739188.pdf | 2022-05-30 07:20 | 227K | ||
| s-0041-1739189.pdf | 2022-05-26 07:20 | 114K | ||
| s-0041-1740047.pdf | 2022-05-25 09:32 | 231K | ||
| s-0041-1740048.pdf | 2022-05-26 10:59 | 403K | ||
| s-0041-1740068.pdf | 2022-05-25 09:29 | 223K | ||
| s-0041-1740069.pdf | 2022-05-25 11:57 | 216K | ||
| s-0041-1740113.pdf | 2022-05-26 07:26 | 381K | ||
| s-0041-1740139.pdf | 2022-05-28 06:43 | 147K | ||
| s-0041-1740313.pdf | 2022-05-26 07:27 | 185K | ||
| s-0041-1740536.pdf | 2022-05-26 07:48 | 192K | ||
| s-0041-1740602.pdf | 2022-05-25 10:00 | 223K | ||
| s-0041-1740603.pdf | 2022-05-26 07:16 | 106K | ||
| s-0041-1740949.pdf | 2022-05-30 07:22 | 170K | ||
| s-0041-1740950.pdf | 2022-05-30 05:07 | 128K | ||
| s-0041-1740951.pdf | 2022-05-26 11:49 | 250K | ||
| s-0041-1741061 (1).pdf | 2022-05-28 06:11 | 559K | ||
| s-0041-1741061.pdf | 2022-05-27 05:37 | 559K | ||
| s-0041-1742078.pdf | 2022-05-30 09:26 | 85K | ||
| s-0041-1742161.pdf | 2022-05-30 07:37 | 88K | ||
| s-0045-1809149.pdf | 2025-07-04 10:30 | 5.5M | ||
| s-0045-1809173.pdf | 2025-07-04 09:22 | 6.7M | ||
| s-0045-1809175.pdf | 2025-07-04 09:29 | 634K | ||
| s-0045-1809301.pdf | 2025-07-04 10:47 | 494K | ||
| s-0045-1809302.pdf | 2025-07-04 10:27 | 5.4M | ||
| s-0045-1809374.pdf | 2025-07-04 10:53 | 148K | ||
| s-0045-1809375.pdf | 2025-07-04 13:07 | 244K | ||
| s-0045-1809376.pdf | 2025-07-04 12:03 | 809K | ||
| s-0045-1809377.pdf | 2025-07-04 10:50 | 3.7M | ||
| s-0045-1809378.pdf | 2025-07-04 12:44 | 413K | ||
| s-0045-1809379.pdf | 2025-07-04 10:59 | 896K | ||
| s-0045-1809446.pdf | 2025-07-04 12:49 | 1.1M | ||
| s-0045-1809447.pdf | 2025-07-04 13:04 | 167K | ||
| s-0045-1809539.pdf | 2025-07-04 13:00 | 176K | ||
| s-0045-1809540.pdf | 2025-07-04 12:51 | 3.0M | ||
| screening-for-early-..> | 2022-03-04 15:14 | 417K | ||
| selinexor—a-drug-r..> | 2021-12-02 08:16 | 264K | ||
| shifting-paradigm-of..> | 2022-02-18 07:16 | 128K | ||
| should-we-look-beyon..> | 2022-05-24 11:07 | 242K | ||
| should-we-look-beyon..> | 2021-12-30 12:55 | 242K | ||
| significance-of-dete..> | 2021-08-13 12:01 | 87K | ||
| smokeless-tobacco-an..> | 2021-12-30 12:57 | 228K | ||
| smokeless-tobacco-an..> | 2021-12-09 05:39 | 1.0M | ||
| soft-tissue-sarcomas..> | 2022-02-18 07:16 | 1.0M | ||
| study-of-the-chromos..> | 2021-09-22 19:16 | 430K | ||
| supplementary/ | 2022-05-30 08:48 | - | ||
| the-cancer-genome-at..> | 2021-12-02 08:16 | 3.1M | ||
| the-future-of-red-ce..> | 2022-01-06 10:48 | 223K | ||
| the-great-breast-can..> | 2021-12-02 08:16 | 193K | ||
| the-interplay-betwee..> | 2022-02-18 07:16 | 176K | ||
| the-nature-of-life.pdf | 2021-08-07 11:53 | 189K | ||
| the-rare-face-of-an-..> | 2021-12-30 12:55 | 362K | ||
| the-true-human-cost-..> | 2021-12-14 11:13 | 1.4M | ||
| to-predict-success-o..> | 2021-08-13 12:01 | 121K | ||
| torn-between-lines-f..> | 2022-03-04 15:14 | 114K | ||
| transient-abnormal-m..> | 2021-09-22 19:16 | 3.0M | ||
| triple-negative-brea..> | 2022-03-15 05:17 | 112K | ||
| two-clinical-cases-o..> | 2022-01-06 10:47 | 170K | ||
| under-the-magnifying..> | 2022-01-06 10:47 | 161K | ||
| under-the-magnifying..> | 2021-12-02 07:10 | 151K | ||
| unilateral-interstit..> | 2022-02-16 11:38 | 2.0M | ||
| universal-germline-g..> | 2022-02-16 11:38 | 149K | ||
| vaccination-against-..> | 2021-08-07 11:53 | 402K | ||
| weekly-etoposide-and..> | 2021-08-13 12:01 | 120K | ||
| what-fascinates-me-i..> | 2021-12-30 12:57 | 126K | ||
| what-fascinates-me-i..> | 2021-11-26 06:09 | 170K | ||
| why-is-china-importi..> | 2021-06-14 17:25 | 315K | ||
| women-for-oncology-1..> | 2022-03-04 11:44 | 111K | ||
| women-for-oncology-2..> | 2022-03-04 11:44 | 95K | ||